TL;DR: Cigna Healthcare modified MM 0052, its genetic testing coverage policy for hereditary and multifactorial conditions, effective October 11, 2025. Billing teams should audit charge capture for 11 CPT codes and one HCPCS code before the effective date.
Cigna Healthcare updated Coverage Policy MM 0052 — the Cigna genetic testing coverage policy governing hereditary and multifactorial conditions — effective October 11, 2025. The revision touches 11 CPT codes and HCPCS code S3852, spanning cardiology, neurology, gastroenterology, autoimmune, and pediatric testing. If your practice bills codes like 0401U, 0439U, or 0440U for coronary heart disease genetic panels, or 0170U for autism spectrum disorder RNA sequencing, this change belongs on your radar now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Genetic Testing for Hereditary and Multifactorial Conditions |
| Policy Code | MM 0052 |
| Change Type | Modified |
| Effective Date | October 11, 2025 |
| Impact Level | High |
| Specialties Affected | Cardiology, Neurology, Gastroenterology, Rheumatology/Autoimmune, Pediatrics, Nephrology, Orthopedics/Genetics, Hematology/Coagulation |
| Key Action | Audit charge capture for all 12 affected codes against MM 0052 and verify plan-level requirements before October 11, 2025 |
Cigna Genetic Testing Coverage Scope Under MM 0052
MM 0052 governs a wide category: inherited or heritable genetic variants — changes in DNA that occur in the egg or sperm at conception and pass through generations. That scope is intentionally broad. It covers single-gene variants, multi-gene panel analyses, and gene expression tests that measure whether a gene is turned on or off.
Multifactorial conditions are explicitly addressed in MM 0052. These are conditions where gene changes combine with lifestyle, environmental, or other factors — like smoking — to produce a disease or trait. The policy scope includes both purely genetic conditions and these combined-factor scenarios.
To understand specific coverage criteria, medical necessity thresholds, and covered indications for each code, you need the full MM 0052 policy document. The summary above describes scope. Coverage determinations require verification against the complete policy and the patient's specific Cigna plan.
Cigna Genetic Testing Codes Under MM 0052
The 12 codes in this policy span multiple specialties. Coverage criteria apply to each code. Confirm plan-level requirements before billing any of them.
Cardiology — Coronary Heart Disease
Codes 0401U (9 genes, 12 variants, targeted variant genotyping), 0439U (5-SNP DNA analysis), and 0440U (10-SNP DNA analysis) all address coronary heart disease genetic risk. Review the full MM 0052 policy for applicable coverage criteria and verify the patient's plan-level requirements before submitting claims.
Neurology — Autism Spectrum Disorder
Code 0170U covers RNA next-generation sequencing from saliva for autism spectrum disorder. This is a neurology/neurodevelopmental indication. Confirm coverage criteria and plan-level requirements before billing.
Gastroenterology — Barrett Esophagus
Code 0398U covers methylation analysis (P16, RUNX3, HPP1, and FBN1) for Barrett esophagus. Verify the full policy criteria and plan-level coverage before submitting.
Nephrology — Chronic Kidney Disease
Code 0355U covers APOL1 risk variants (G1, G2) for chronic kidney disease. Confirm coverage criteria and plan-level requirements before billing.
Pediatrics — Kawasaki Disease
Code 0389U covers IFI27 and related markers for pediatric febrile illness and Kawasaki disease. Verify coverage criteria and plan-level requirements before submitting.
Neurodevelopmental / Genetics — Intellectual Disability
Code 0156U covers copy number sequence analysis for intellectual disability and dysmorphology. Confirm coverage criteria and plan-level requirements before billing.
Hematology/Coagulation
Code 81291 covers MTHFR gene analysis for hereditary hypercoagulability. Review MM 0052 for applicable coverage criteria before submitting claims for Cigna patients.
Rheumatology/Autoimmune
Code 81490 covers a 12-biomarker immunoassay panel for rheumatoid arthritis. Confirm coverage criteria and plan-level requirements before billing.
Orthopedics/Genetics — Scoliosis
Code 0004M covers DNA analysis of 53 SNPs from saliva using a prognostic algorithm for scoliosis. Verify coverage criteria and plan-level requirements before submitting.
Neurology/Genetics — Alzheimer's Susceptibility
HCPCS code S3852 covers DNA analysis for the APOE epsilon 4 allele for Alzheimer's disease susceptibility. Confirm coverage criteria and plan-level requirements before billing.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Coronary heart disease — targeted variant genotyping, 9 genes/12 variants | Coverage criteria apply | 0401U | Verify full MM 0052 criteria and plan-level requirements |
| Coronary heart disease — 5-SNP DNA analysis | Coverage criteria apply | 0439U | Verify full MM 0052 criteria and plan-level requirements |
| Coronary heart disease — 10-SNP DNA analysis | Coverage criteria apply | 0440U | Verify full MM 0052 criteria and plan-level requirements |
| Autism spectrum disorder — RNA next-gen sequencing, saliva | Coverage criteria apply | 0170U | Verify full MM 0052 criteria and plan-level requirements |
| Intellectual disability/dysmorphology — copy number sequence analysis | Coverage criteria apply | 0156U | Verify full MM 0052 criteria and plan-level requirements |
| Barrett esophagus — methylation analysis (P16, RUNX3, HPP1, FBN1) | Coverage criteria apply | 0398U | Verify full MM 0052 criteria and plan-level requirements |
| Chronic kidney disease — APOL1 risk variants (G1, G2) | Coverage criteria apply | 0355U | Verify full MM 0052 criteria and plan-level requirements |
| Kawasaki disease — IFI27 and related markers, pediatric febrile illness | Coverage criteria apply | 0389U | Verify full MM 0052 criteria and plan-level requirements |
| MTHFR gene analysis for hereditary hypercoagulability | Coverage criteria apply | 81291 | Verify full MM 0052 criteria and plan-level requirements |
| Rheumatoid arthritis — 12-biomarker immunoassay panel | Coverage criteria apply | 81490 | Verify full MM 0052 criteria and plan-level requirements |
| Scoliosis — 53-SNP DNA analysis, saliva | Coverage criteria apply | 0004M | Verify full MM 0052 criteria and plan-level requirements |
| Alzheimer's susceptibility — APOE epsilon 4 allele | Coverage criteria apply | S3852 (HCPCS) | Verify full MM 0052 criteria and plan-level requirements |
Cigna Genetic Testing Billing Guidelines and Action Items 2025
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for all 12 codes in MM 0052 before October 11, 2025. Pull claims from the past 12 months for CPT codes 0004M, 0156U, 0170U, 0355U, 0389U, 0398U, 0401U, 0439U, 0440U, 81291, 81490, and HCPCS S3852. Flag any claims where documentation may not align with the updated policy. |
| 2 | Obtain and read the full MM 0052 policy document before the effective date. The summary in this post describes the policy's scope — inherited genetic variants, single-gene tests, multi-gene panels, and gene expression tests. The full policy document contains the specific coverage criteria your billing team needs to assess each code correctly. |
| 3 | Verify plan-level requirements for each affected code. Cigna plan types do not always apply policy criteria uniformly. For every patient where you're billing one of these 12 codes, check the specific plan's requirements before submitting. |
| 4 | Separate multifactorial condition documentation from standard genetic test orders. MM 0052 explicitly addresses conditions influenced by both genetic variants and non-genetic factors like lifestyle, environment, and smoking. For codes that fall into this category, documentation should reflect the clinical context. Review the full policy for what that documentation needs to include. |
| 5 | Flag high-volume codes for internal review before October 11. If your practice bills several of these codes at high volume — particularly the cardiology panels (0401U, 0439U, 0440U) or 81291 — review ordering patterns against the full MM 0052 policy before the effective date. |
| 6 | Build a denial tracking workflow for MM 0052 codes. If claims for any of these 12 codes are denied after October 11, document the denial reason and cross-reference it against the full MM 0052 policy language. That's the foundation for any appeal. |
If your practice sees high volume across multiple specialties — cardiology, neurology, and GI all in play — talk to your compliance officer before October 11 about whether you need a formal internal audit. The breadth of MM 0052 across 12 codes and eight specialties creates compounding exposure.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Genetic Testing Under MM 0052
CPT Codes (Coverage Criteria Apply — Verify Plan-Level Requirements)
| Code | Type | Description |
|---|---|---|
| 0004M | CPT | Scoliosis, DNA analysis of 53 single nucleotide polymorphisms (SNPs), using saliva, prognostic algorithm |
| 0156U | CPT | Copy number (e.g., intellectual disability, dysmorphology), sequence analysis |
| 0170U | CPT | Neurology (autism spectrum disorder [ASD]), RNA, next-generation sequencing, saliva, algorithmic analysis |
| 0355U | CPT | APOL1 (apolipoprotein L1) (e.g., chronic kidney disease), risk variants (G1, G2) |
| 0389U | CPT | Pediatric febrile illness (Kawasaki disease [KD]), interferon alpha-inducible protein 27 (IFI27) and related markers |
| 0398U | CPT | Gastroenterology (Barrett esophagus), P16, RUNX3, HPP1, and FBN1 DNA methylation analysis using PCR |
| 0401U | CPT | Cardiology (coronary heart disease [CHD]), 9 genes (12 variants), targeted variant genotyping, blood |
| 0439U | CPT | Cardiology (coronary heart disease [CHD]), DNA, analysis of 5 single-nucleotide polymorphisms (SNPs) |
| 0440U | CPT | Cardiology (coronary heart disease [CHD]), DNA, analysis of 10 single-nucleotide polymorphisms (SNPs) |
| 81291 | CPT | MTHFR (5,10-methylenetetrahydrofolate reductase) (e.g., hereditary hypercoagulability) gene analysis |
| 81490 | CPT | Autoimmune (rheumatoid arthritis), analysis of 12 biomarkers using immunoassays, utilizing serum |
HCPCS Codes (Coverage Criteria Apply — Verify Plan-Level Requirements)
| Code | Type | Description |
|---|---|---|
| S3852 | HCPCS | DNA analysis for APOE epsilon 4 allele for susceptibility to Alzheimer's disease |
No ICD-10-CM codes are listed in the MM 0052 policy data. Diagnosis code selection should follow standard coding guidelines for each condition and align with the ordering physician's documented indication.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.